Radiopharm Theranostics (ASX:RAD) Scaled Net Operating Assets : 0.30 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Radiopharm Theranostics's operating assets for the quarter that ended in Dec. 2023 was A$61.40 Mil. Radiopharm Theranostics's operating liabilities for the quarter that ended in Dec. 2023 was A$38.95 Mil. Radiopharm Theranostics's Total Assets for the quarter that ended in Jun. 2023 was A$74.95 Mil. Therefore, Radiopharm Theranostics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.30.

Radiopharm Theranostics Scaled Net Operating Assets Historical Data

The historical data trend for Radiopharm Theranostics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Scaled Net Operating Assets Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Jun24

Scaled Net Operating Assets

0.43

0.41

0.12

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial			0.40	0.47	0.40	0.30	0.14

Competitive Comparison of Radiopharm Theranostics's Scaled Net Operating Assets

For the Biotechnology subindustry, Radiopharm Theranostics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Scaled Net Operating Assets falls into.

Radiopharm Theranostics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Radiopharm Theranostics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2024 )
=	(Operating Assets (A: Jun. 2024 )	-	Operating Liabilities (A: Jun. 2024 ))	/	Total Assets (A: Jun. 2023 )
=	(53.461	-	44.683)	/	74.95
=	0.12

where

	Operating Assets		(A: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	72.036	-	18.575
=	53.461

	Operating Liabilities		(A: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	44.683	-	0	-	0
=	44.683

Radiopharm Theranostics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(61.399	-	38.95)	/	74.95
=	0.30

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	63.293	-	1.894
=	61.399

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	38.95	-	0	-	0
=	38.95

Radiopharm Theranostics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics Headlines

No Headlines